In an observational US target trial emulation, glucagon-like peptide-1 receptor agonist initiation was associated with about 3 to 4 more ischemic optic neuropathy cases per 10,000 patients over 18 months than two comparator drug classes.
Edited
Andrea Surnit
Conexiant July 13, 2026
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Bio:Andrea Surnit is an editor for Conexiant whose work includes cardiology news and journal coverage. She edited Conexiant reporting on proactive care coordination for older Medicare patients with cardiovascular disease or cardiovascular risk factors.
